(ZYME) Zymeworks Common - Performance 48.4% in 12m
ZYME performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-40.08%
#59 in Peer-Group
Rel. Strength
86.38%
#1037 in Stock-Universe
Total Return 12m
48.36%
#26 in Peer-Group
Total Return 5y
-64.43%
#74 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 17.40 USD |
| 52 Week Low | 8.36 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 70.49 |
| Buy/Sell Signal +-5 | 0.26 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ZYME (48.4%) vs XBI (-7.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
10.4% | 76.6% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-6.77% | -4.62% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
9.62% | 0.48% | 57% | 26.8 | 13.9 | 0.97 | 0.60% | 41% |
| BIM PA Biomerieux |
2.27% | 33.8% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.43% | -8.06% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
13.1% | 44.8% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
0.29% | 36.9% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
8.57% | 17.2% | 11.2% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: ZYME vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ZYME
| Total Return (including Dividends) | ZYME | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 9.89% | 7.76% | 1.11% |
| 3 Months | 0.72% | -5.31% | 5.58% |
| 12 Months | 48.36% | -7.58% | 10.51% |
| 5 Years | -64.43% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | ZYME | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 66.6% | 84.2% | 69.9% |
| 3 Months | 1.3% | -2.8% | 69.3% |
| 12 Months | 32% | -77.8% | 43.2% |
| 5 Years | -41.3% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #93 | 1.97% | 8.68% |
| 3 Month | #87 | 6.36% | -4.61% |
| 12 Month | #27 | 60.53% | 34.25% |
| 5 Years | #78 | -56.33% | -82.99% |
FAQs
Does Zymeworks Common (ZYME) outperform the market?
Yes,
over the last 12 months ZYME made 48.36%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.58%.
Over the last 3 months ZYME made 0.72%, while XBI made -5.31%.
Performance Comparison ZYME vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ZYME vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.2% | 8.8% | -7% | 38% |
| US NASDAQ 100 | QQQ | 2.5% | 8.4% | -6.2% | 39% |
| German DAX 40 | DAX | 4.4% | 10.6% | -23.3% | 19% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.5% | 10.8% | -8.8% | 37% |
| Hongkong Hang Seng | HSI | 1.7% | 4.8% | -26% | 21% |
| India NIFTY 50 | INDA | 3.9% | 11.2% | -6% | 50% |
| Brasil Bovespa | EWZ | -0.1% | 9.4% | -27.2% | 39% |
ZYME vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.6% | 8.4% | -9.8% | 26% |
| Consumer Discretionary | XLY | 2.8% | 11.7% | 2.9% | 31% |
| Consumer Staples | XLP | 2.5% | 10.1% | -8.5% | 41% |
| Energy | XLE | -3.7% | 7% | -10.6% | 45% |
| Financial | XLF | 3.8% | 12.5% | -9.8% | 25% |
| Health Care | XLV | 0.3% | 5.5% | -6.5% | 53% |
| Industrial | XLI | 3.3% | 9.6% | -12.5% | 30% |
| Materials | XLB | 2.9% | 8.5% | -7.8% | 49% |
| Real Estate | XLRE | 1.7% | 8.9% | -8% | 35% |
| Technology | XLK | 1.9% | 7.9% | -7.4% | 44% |
| Utilities | XLU | 0.8% | 9.4% | -15.3% | 27% |
| Aerospace & Defense | XAR | 3.2% | 4.1% | -23.9% | 6% |
| Biotech | XBI | 2.6% | 2.1% | 3.8% | 56% |
| Homebuilder | XHB | 3.8% | 14.9% | 8.4% | 58% |
| Retail | XRT | 6.1% | 10.1% | 1% | 48% |
ZYME vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -9.6% | -8.80% | -16.8% | 45% |
| Natural Gas | UNG | 3% | 12.5% | -25.3% | 63% |
| Gold | GLD | -1.4% | 3.7% | -37.2% | 1% |
| Silver | SLV | 3% | -1.5% | -26.6% | 26% |
| Copper | CPER | 4.7% | 8.2% | -21.9% | 40% |
ZYME vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.7% | 9.2% | -5.6% | 52% |
| iShares High Yield Corp. Bond | HYG | 1.7% | 9.4% | -10.7% | 39% |